Sanchez Machado, M., Upadhyaya, S. A., Gadiraju, S., Santhosh, M., Gaba, J., Mcdonnell, P. J., . . . Barrero, C. A. (2026). Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy. Cancers, 18(13), 2163. https://doi.org/10.3390/cancers18132163
Chicago Style (17th ed.) CitationSanchez Machado, Mathias, Sangnya A. Upadhyaya, Saipriya Gadiraju, Matthew Santhosh, John Gaba, Patrick J. Mcdonnell, Jacobo Hincapie-Echeverri, and Carlos A. Barrero. "Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy." Cancers 18, no. 13 (2026): 2163. https://doi.org/10.3390/cancers18132163.
MLA (9th ed.) CitationSanchez Machado, Mathias, et al. "Rational Immune Checkpoint Inhibitor-Based Combination Immunotherapy in Cancer: Mechanistic Design, Biomarker Selection, and Implications for Oncology Pharmacy." Cancers, vol. 18, no. 13, 2026, p. 2163, https://doi.org/10.3390/cancers18132163.